↓ Cooling
Business
Roche Halts Development of Obesity Drug Candidate
Roche has halted the development of emugrobart, a muscle-preserving obesity drug candidate, following a failed interim analysis.
1 trends tracked about this subject — the full history, oldest to newest below.
Roche has halted the development of emugrobart, a muscle-preserving obesity drug candidate, following a failed interim analysis.